Kalshi seeks to launch ‘perps’ on equity indexes as it moves in on traditional exchanges' turf
The company is seeking to launch a "US500" perp tied to the MerQube U.S. Large Cap Index, according to a regulatory filing.
The company is seeking to launch a "US500" perp tied to the MerQube U.S. Large Cap Index, according to a regulatory filing.
Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI.
Three firms initiated coverage of the the gene-based therapeutics company.
My fiance's grandparents funded a custodial account for him in the 90s—a move which comes with major financial implications now that he's an adult.
Taxpayers who were unsure whether they qualified or how much they could claim will likely have an easier time when they file their 2026 tax returns, expert say.
If you need funding in a pinch, follow these steps for getting a personal loan the same (or next business) day.
Incumbent Republican Sen. Dan Sullivan of Alaska is facing a serious challenge from former Democratic Rep. Mary Peltola.
Andrei Klepach was reportedly fired from his role after presenting a report warning that Russia could not win a prolonged war of attrition with Ukraine.
Home Depot reported second fiscal quarter results that beat Wall Street expectations on the top and bottom lines.
International government bond yields followed U.S. Treasury yields higher on Tuesday.
While English football clubs are gaining popularity with investors across the globe, teams remain risky and often unprofitable ventures.
The yield on the 30-year U.S. Treasury has surged to its highest level in 19 years, and some strategists see scope for the move to go further.
Boost your short-term savings with the top 6-month CDs.
These are the stocks posting the largest moves premarket.
Qualcomm is trying to move into the data center business, where Nvidia has been the dominant player in the AI boom.
OpenAI's Astra model is generating a lot of buzz, and Intel shares are up almost 5% premarket.
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
Eighteen maritime bodies warned Tuesday that geopolitical tensions and a growing shadow fleet threaten to undermine international shipping and weaken trade.
Comprehensive industry legislation teeters on the brink amid growing doubts the bill will cross the finish line.